Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Helicobacter Pylori-Negative MALT Lymphoma: A Series of Two Cases Presenting with Life-Threatening Upper Gastrointestinal Bleeding. | Case Rep Gastrointest Med | 2023 | 37009207 | PubTator, text mining | PubMed |
| Evasion strategies of porcine reproductive and respiratory syndrome virus. | Front Microbiol | 2023 | 37007469 | PubTator, text mining | PubMed |
| Exploiting antifungal immunity in the clinical context. | Semin Immunol | 2023 | 37001464 | PubTator, text mining | PubMed |
| LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review. | Biomolecules | 2023 | 36979495 | PubTator, text mining | PubMed |
| Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review. | Asian Pac J Cancer Prev | 2023 | 36974526 | PubTator, text mining | PubMed |
| Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer. | Front Oncol | 2023 | 36969062 | PubTator, text mining | PubMed |
| A horse or a zebra? Unusual manifestations of common cutaneous infections in primary immunodeficiency pediatric patients. | Front Pediatr | 2023 | 36950172 | PubTator, text mining | PubMed |
| Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization. | PeerJ | 2023 | 36949762 | PubTator, text mining | PubMed |
| Daytime administration of melatonin has better protective effects on bone loss in ovariectomized rats. | J Orthop Surg Res | 2023 | 36949499 | PubTator, text mining | PubMed |
| Early gastric mucosa-associated lymphoid tissue lymphoma treated by endoscopic submucosal dissection. | Endoscopy | 2023 | 36931301 | PubTator, text mining | PubMed |
| CARD-only proteins regulate in vivo inflammasome responses and ameliorate gout. | Cell Rep | 2023 | 36930645 | PubTator, text mining | PubMed |
| Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas. | Nat Mater | 2023 | 36928381 | PubTator, text mining | PubMed |
| MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas. | Blood Cancer J | 2023 | 36922488 | PubTator, text mining | PubMed |
| Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells. | Proc Natl Acad Sci U S A | 2023 | 36920923 | PubTator, text mining | PubMed |
| NFκB signaling in T cell memory. | Front Immunol | 2023 | 36911729 | PubTator, text mining | PubMed |
| Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment. | Front Genet | 2023 | 36911393 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. | Molecules | 2023 | 36903645 | PubTator, text mining | PubMed |
| Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer. | Cells | 2023 | 36899924 | PubTator, text mining | PubMed |
| Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL. | Cancer Manag Res | 2023 | 36873252 | PubTator, text mining | PubMed |
| Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism. | Front Nutr | 2023 | 36866057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=18